We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+25.16%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.46B
AUM Growth
+$147M
Cap. Flow
-$82.7M
Cap. Flow %
-5.66%
Top 10 Hldgs %
25.13%
Holding
215
New
28
Increased
57
Reduced
41
Closed
25

Top Buys

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$31.1M
2
MRK icon
Merck
MRK
+$27.8M
3
MIRM icon
Mirum Pharmaceuticals
MIRM
+$24.3M
4
IMGN
Immunogen Inc
IMGN
+$14.5M
5
XENE icon
Xenon Pharmaceuticals
XENE
+$14.1M

Top Sells

Rank Stock Value
1
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$29.3M
2
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$28.4M
3
UTHR icon
United Therapeutics
UTHR
+$26.8M
4
SRPT icon
Sarepta Therapeutics
SRPT
+$25.8M
5
PODD icon
Insulet
PODD
+$23.6M

Sector Composition

Rank Sector Weight
1 Healthcare 53.92%
2 Technology 13.34%
3 Industrials 8.74%
4 Consumer Discretionary 4.85%
5 Energy 4.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CCB icon
126
Coastal Financial
CCB
$693M
$1.49M 0.1%
39,661
– –
GPK icon
127
Graphic Packaging
GPK
$3.58B
$1.45M 0.1%
60,439
+16,801
+39% +$422K
WT icon
128
WisdomTree
WT
$3.22B
$1.37M 0.09%
+199,046
New +$1.33M
LPLA icon
129
LPL Financial
LPLA
$28.6B
$1.31M 0.09%
6,039
-2,827
-32% -$566K
TSLA icon
130
Tesla
TSLA
$1.3T
$1.21M 0.08%
4,611
+665
+17% +$133K
HUBS icon
131
HubSpot
HUBS
$10.5B
$1.19M 0.08%
2,244
+657
+41% +$308K
MRTN icon
132
Marten Transport
MRTN
$1.22B
$1.16M 0.08%
54,012
-8,238
-13% -$173K
VKTX icon
133
Viking Therapeutics
VKTX
$4B
$1.12M 0.08%
68,905
-438,165
-86% -$9.18M
DDOG icon
134
Datadog
DDOG
$84B
$1.07M 0.07%
10,848
– –
LRCX icon
135
Lam Research
LRCX
$390B
$1.05M 0.07%
16,290
– –
WW
136
DELISTED
WW International
WW
$926K 0.06%
+137,750
New +$976K
BXSL icon
137
Blackstone Secured Lending
BXSL
$5.72B
$907K 0.06%
+33,151
New +$854K
INTU icon
138
Intuit
INTU
$89B
$907K 0.06%
1,979
– –
PANW icon
139
Palo Alto Networks
PANW
$297B
$889K 0.06%
6,958
+150
+2% +$15.6K
GNRC icon
140
Generac Holdings
GNRC
$12.5B
$825K 0.06%
+5,535
New +$631K
ABNB icon
141
Airbnb
ABNB
$107B
$766K 0.05%
5,975
-17,027
-74% -$1.99M
DNA icon
142
Ginkgo Bioworks
DNA
$521M
$626K 0.04%
8,415
– –
ONON icon
143
On Holding
ONON
$12.5B
$607K 0.04%
18,403
+5,696
+45% +$173K
MBLY icon
144
Mobileye
MBLY
$2.2B
$561K 0.04%
14,599
+500
+4% +$20.3K
TOL icon
145
Toll Brothers
TOL
$14.5B
$534K 0.04%
6,757
-3,694
-35% -$248K
JBHT icon
146
JB Hunt Transport Services
JBHT
$25.2B
$517K 0.04%
2,857
-3,402
-54% -$592K
FLS icon
147
Flowserve
FLS
$10.2B
$515K 0.04%
+13,873
New +$481K
XPO icon
148
XPO
XPO
$23.7B
$476K 0.03%
+8,066
New +$365K
IWO icon
149
iShares Russell 2000 Growth ETF
IWO
$15.1B
$417K 0.03%
1,718
-1,777
-51% -$407K
TSCO icon
150
Tractor Supply
TSCO
$18B
$395K 0.03%
8,935
-13,745
-61% -$630K
4 5
6
7 8

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q2 2023 Portfolio in Review

As of Q2 2023, Nicholas Investment Partners held 215 positions worth $1.46B, up 11% from $1.32B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Nicholas Investment Partners withdrew a net $82.7M in Q2 2023, closing 25 positions and reducing 41 holdings. Its most notable exit was Prometheus Biosciences, Inc. Common Stock, an estimated $29.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 54% of assets, up from 53% a quarter earlier, followed by Technology and Industrials.

Against the trend, Nicholas Investment Partners opened a new position in Intra-Cellular Therapies Inc. worth $31.6M.

  • Nicholas Investment Partners's largest Q2 2023 buy was Intra-Cellular Therapies Inc.: 499,503 shares worth $31.6M.
  • Nicholas Investment Partners added most to Xenon Pharmaceuticals in Q2 2023, an estimated $14.1M increase.
  • Nicholas Investment Partners's biggest Q2 2023 reduction was Lantheus, cutting an estimated $9.72M.
  • Nicholas Investment Partners fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $29.3M.
  • Nicholas Investment Partners's ten largest holdings make up 25% of its $1.46B portfolio in Q2 2023.
  • Nicholas Investment Partners opened 28 new positions and closed 25 in Q2 2023.
  • Nicholas Investment Partners's portfolio value rose 11% quarter-over-quarter to $1.46B.

Based on Nicholas Investment Partners's 13F filing for Q2 2023, filed 10 Aug 2023.